Titre : Tumeurs du thorax

Tumeurs du thorax : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs du thorax : Questions médicales les plus fréquentes", "headline": "Tumeurs du thorax : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs du thorax : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-21", "dateModified": "2025-03-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs du thorax" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs par siège", "url": "https://questionsmedicales.fr/mesh/D009371", "about": { "@type": "MedicalCondition", "name": "Tumeurs par siège", "code": { "@type": "MedicalCode", "code": "D009371", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adénocarcinome pulmonaire", "alternateName": "Adenocarcinoma of Lung", "url": "https://questionsmedicales.fr/mesh/D000077192", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome pulmonaire", "code": { "@type": "MedicalCode", "code": "D000077192", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.520.055" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adénocarcinome bronchioloalvéolaire", "alternateName": "Adenocarcinoma, Bronchiolo-Alveolar", "url": "https://questionsmedicales.fr/mesh/D002282", "about": { "@type": "MedicalCondition", "name": "Adénocarcinome bronchioloalvéolaire", "code": { "@type": "MedicalCode", "code": "D002282", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.520.055.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Blastome pulmonaire", "alternateName": "Pulmonary Blastoma", "url": "https://questionsmedicales.fr/mesh/D018202", "about": { "@type": "MedicalCondition", "name": "Blastome pulmonaire", "code": { "@type": "MedicalCode", "code": "D018202", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.520.867" } } }, { "@type": "MedicalWebPage", "name": "Tumeurs fibreuses solitaires de la plèvre", "alternateName": "Solitary Fibrous Tumor, Pleural", "url": "https://questionsmedicales.fr/mesh/D054363", "about": { "@type": "MedicalCondition", "name": "Tumeurs fibreuses solitaires de la plèvre", "code": { "@type": "MedicalCode", "code": "D054363", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.894.797.640.800" } } } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs du thorax", "alternateName": "Thoracic Neoplasms", "code": { "@type": "MedicalCode", "code": "D013899", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yan Wang", "url": "https://questionsmedicales.fr/author/Yan%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China." } }, { "@type": "Person", "name": "Naseema Gangat", "url": "https://questionsmedicales.fr/author/Naseema%20Gangat", "affiliation": { "@type": "Organization", "name": "Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "Anja C Roden", "url": "https://questionsmedicales.fr/author/Anja%20C%20Roden", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN." } }, { "@type": "Person", "name": "Marianne Pavel", "url": "https://questionsmedicales.fr/author/Marianne%20Pavel", "affiliation": { "@type": "Organization", "name": "Department of Medicine, University Hospital Erlangen, Erlangen, Germany." } }, { "@type": "Person", "name": "Dermot O'Toole", "url": "https://questionsmedicales.fr/author/Dermot%20O%27Toole", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Risk factors for jaw osteoradionecrosis: a case control study.", "datePublished": "2022-11-11", "url": "https://questionsmedicales.fr/article/36383838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1807-3107bor-2022.vol36.0132" } }, { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://questionsmedicales.fr/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par siège", "item": "https://questionsmedicales.fr/mesh/D009371" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du thorax", "item": "https://questionsmedicales.fr/mesh/D013899" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs du thorax - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs du thorax", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs du thorax", "description": "Comment diagnostiquer une tumeur thoracique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés aux tumeurs thoraciques ?\nQuelle est l'importance de l'histologie ?\nLes examens génétiques sont-ils utiles ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs du thorax", "description": "Quels sont les symptômes courants des tumeurs thoraciques ?\nLa perte de poids est-elle un symptôme ?\nLes tumeurs thoraciques causent-elles des saignements ?\nComment la fatigue se manifeste-t-elle ?\nLes symptômes varient-ils selon le type de tumeur ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs du thorax", "description": "Comment prévenir les tumeurs thoraciques ?\nLe dépistage est-il utile ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique aide-t-il à prévenir ?\nLes vaccinations sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs du thorax", "description": "Quels traitements sont disponibles pour les tumeurs thoraciques ?\nLa chirurgie est-elle toujours nécessaire ?\nQu'est-ce que la chimiothérapie néoadjuvante ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements ciblés disponibles ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs du thorax", "description": "Quelles complications peuvent survenir ?\nLes tumeurs thoraciques peuvent-elles causer des douleurs ?\nComment les tumeurs affectent-elles la respiration ?\nLes tumeurs peuvent-elles provoquer des caillots sanguins ?\nQuelles sont les complications post-chirurgicales ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs du thorax", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'exposition professionnelle est-elle un facteur ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur thoracique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (radiographie, scanner) et biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la tomodensitométrie, l'IRM et la bronchoscopie." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont associés aux tumeurs thoraciques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme le CEA et le CA 125 peuvent être utilisés pour le suivi." } }, { "@type": "Question", "name": "Quelle est l'importance de l'histologie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'histologie permet de déterminer le type de tumeur et son agressivité." } }, { "@type": "Question", "name": "Les examens génétiques sont-ils utiles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à identifier des mutations spécifiques pour le traitement ciblé." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs thoraciques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la toux persistante, la douleur thoracique et l'essoufflement." } }, { "@type": "Question", "name": "La perte de poids est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la perte de poids inexpliquée peut être un signe de tumeur thoracique." } }, { "@type": "Question", "name": "Les tumeurs thoraciques causent-elles des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des hémoptysies, c'est-à-dire des saignements dans les voies respiratoires." } }, { "@type": "Question", "name": "Comment la fatigue se manifeste-t-elle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue peut être persistante et s'aggraver avec l'évolution de la maladie." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type et la localisation de la tumeur." } }, { "@type": "Question", "name": "Comment prévenir les tumeurs thoraciques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et l'exposition à des agents cancérigènes aide à prévenir." } }, { "@type": "Question", "name": "Le dépistage est-il utile ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut aider à détecter les tumeurs à un stade précoce." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire le risque de développer des tumeurs." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut contribuer à réduire le risque de cancer." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers associés." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs thoraciques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, la chirurgie dépend du stade et de la localisation de la tumeur." } }, { "@type": "Question", "name": "Qu'est-ce que la chimiothérapie néoadjuvante ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "C'est un traitement administré avant la chirurgie pour réduire la taille de la tumeur." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour traiter les tumeurs non opérables ou en complément." } }, { "@type": "Question", "name": "Y a-t-il des traitements ciblés disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des thérapies ciblées sont disponibles pour certains types de tumeurs spécifiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la métastase, l'infection et l'insuffisance respiratoire." } }, { "@type": "Question", "name": "Les tumeurs thoraciques peuvent-elles causer des douleurs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des douleurs thoraciques dues à la pression sur les nerfs." } }, { "@type": "Question", "name": "Comment les tumeurs affectent-elles la respiration ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent obstruer les voies respiratoires, entraînant des difficultés respiratoires." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles provoquer des caillots sanguins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent augmenter le risque de thrombose veineuse profonde." } }, { "@type": "Question", "name": "Quelles sont les complications post-chirurgicales ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des infections, des saignements et des problèmes respiratoires." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à l'amiante et les antécédents familiaux sont des facteurs clés." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de tumeurs thoraciques augmente avec l'âge." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer augmentent le risque de développer des tumeurs thoraciques." } }, { "@type": "Question", "name": "L'exposition professionnelle est-elle un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines professions exposent à des substances cancérigènes, augmentant le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...